These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 30918071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target.
    Li D, Wei T, Rawle DJ, Qin F, Wang R, Soares DC, Jin H, Sivakumaran H, Lin MH, Spann K, Abbott CM, Harrich D.
    PLoS Pathog; 2015 Dec; 11(12):e1005289. PubMed ID: 26624286
    [Abstract] [Full Text] [Related]

  • 4. eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency.
    Li D, Rawle DJ, Wu Z, Jin H, Lin MH, Lor M, Abbott CM, Harrich D.
    Virology; 2019 Apr; 530():65-74. PubMed ID: 30782564
    [Abstract] [Full Text] [Related]

  • 5. Binding of the eukaryotic translation elongation factor 1A with the 5'UTR of HIV-1 genomic RNA is important for reverse transcription.
    Li D, Wei T, Jin H, Rose A, Wang R, Lin MH, Spann K, Harrich D.
    Virol J; 2015 Aug 06; 12():118. PubMed ID: 26242867
    [Abstract] [Full Text] [Related]

  • 6. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
    Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM.
    J Virol; 2005 Sep 06; 79(18):12045-57. PubMed ID: 16140780
    [Abstract] [Full Text] [Related]

  • 7. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P, Prasad VR.
    J Virol; 2002 Jul 06; 76(13):6545-57. PubMed ID: 12050367
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors.
    Sluis-Cremer N, Tachedjian G.
    Virus Res; 2008 Jun 06; 134(1-2):147-56. PubMed ID: 18372072
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN.
    J Virol; 2004 Dec 06; 78(24):13553-61. PubMed ID: 15564466
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
    Contreras-Galindo R, Dube D, Fujinaga K, Kaplan MH, Markovitz DM.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931682
    [Abstract] [Full Text] [Related]

  • 12. Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.
    Tekeste SS, Wilkinson TA, Weiner EM, Xu X, Miller JT, Le Grice SF, Clubb RT, Chow SA.
    J Virol; 2015 Dec 01; 89(23):12058-69. PubMed ID: 26401032
    [Abstract] [Full Text] [Related]

  • 13. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C.
    Mol Pharmacol; 2000 Nov 01; 58(5):1100-8. PubMed ID: 11040059
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of aqueous Dandelion extract on HIV-1 replication and reverse transcriptase activity.
    Han H, He W, Wang W, Gao B.
    BMC Complement Altern Med; 2011 Nov 14; 11():112. PubMed ID: 22078030
    [Abstract] [Full Text] [Related]

  • 15. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL, Ahmed PS, Chambers P, Tyms AS, Bedard J, Duchaine J, Falardeau G, Lavallée JF, Brown W, Rando RF, Bowlin T.
    Antivir Chem Chemother; 1999 Mar 14; 10(2):79-86. PubMed ID: 10335402
    [Abstract] [Full Text] [Related]

  • 16. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
    Boyer PL, Smith SJ, Zhao XZ, Das K, Gruber K, Arnold E, Burke TR, Hughes SH.
    J Virol; 2018 Jul 01; 92(13):. PubMed ID: 29643235
    [Abstract] [Full Text] [Related]

  • 17. Two Coselected Distal Mutations in HIV-1 Reverse Transcriptase (RT) Alter Susceptibility to Nonnucleoside RT Inhibitors and Nucleoside Analogs.
    Boyer PL, Melody K, Smith SJ, Dunn LL, Kline C, Fischer DK, Dwivedi R, Clark P, Hughes SH, Ambrose Z.
    J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30894467
    [Abstract] [Full Text] [Related]

  • 18. Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants.
    Dykes C, Fox K, Lloyd A, Chiulli M, Morse E, Demeter LM.
    Virology; 2001 Jul 05; 285(2):193-203. PubMed ID: 11437654
    [Abstract] [Full Text] [Related]

  • 19. Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.
    Huang W, Gamarnik A, Limoli K, Petropoulos CJ, Whitcomb JM.
    J Virol; 2003 Jan 05; 77(2):1512-23. PubMed ID: 12502865
    [Abstract] [Full Text] [Related]

  • 20. Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
    Figueiredo A, Moore KL, Mak J, Sluis-Cremer N, de Bethune MP, Tachedjian G.
    PLoS Pathog; 2006 Nov 05; 2(11):e119. PubMed ID: 17096588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.